ENOV
Enovis Corporation
ENOV has the edge over RKLB overall, supported by lower modeled downside and stronger fundamentals.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ENOV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Healthy |
ENOV's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ENOV PE Valuation
ENOV has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
ENOV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ENOV, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ENOV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.56 | — |
| Q3 2026 | -$9.25 | +$15.05 |
| Q2 2026 | -$19.30 | -$4.41 |
| Q1 2026 | -$19.92 | -$5.33 |
| Q4 2025 | -$20.75 | -$5.82 |
| Q3 2025 | -$24.30 | -$22.11 |
| Q2 2025 | -$14.89 | -$13.23 |
| Q1 2025 | -$14.59 | -$13.09 |
| Q4 2024 | -$14.93 | -$14.32 |
ENOV is still losing money, but far less than before: $9.25 per share over the past year, against $24.30 at its worst in late 2025.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB has the edge over ENOV on earnings, with more consistent year-over-year improvement.
ENOV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $558.7M | +1.8% |
| Q2 2026 | $582.8M | +3.2% |
| Q1 2026 | $589.2M | +5.4% |
| Q4 2025 | $575.8M | +2.6% |
| Q3 2025 | $548.9M | +8.6% |
| Q2 2025 | $564.5M | +7.5% |
| Q1 2025 | $558.8M | +8.2% |
| Q4 2024 | $561M | +23% |
ENOV's revenue has grown year over year for 14 quarters in a row: $559M last quarter, up 1.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.6% | +102 points |
| Q2 2026 | 3% | +6 points |
| Q1 2026 | 1.1% | +9.5 points |
| Q4 2025 | -87% | +31 points |
| Q3 2025 | -102% | -96 points |
| Q2 2025 | -3% | +5.4 points |
| Q1 2025 | -8.4% | -1.6 points |
| Q4 2024 | -119% | -117 points |
ENOV has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over ENOV on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
ENOV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $35M | +20% |
| Q2 2026 | $31.1M | +816% |
| Q1 2026 | -$28.9M | +$16M |
| Q4 2025 | $32.3M | -8.1% |
| Q3 2025 | $29.1M | +1128% |
| Q2 2025 | $3.4M | +$35M |
| Q1 2025 | -$44.9M | +$28.2M |
| Q4 2024 | $35.1M | -13% |
ENOV has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
ENOV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +892K shares |
| 1 year | +2.3% | +1.3M shares |
| 3 years | +7.2% | +3.9M shares |
| 5 years | +8.9% | +4.8M shares |
| Available history | +28% | +12.9M shares |
ENOV has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ENOV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.7x | High |
| Q4 2025 | 5.7x | High |
| Q2 2025 | 7.9x | High |
| Q1 2025 | 6.6x | High |
| Q4 2024 | 8.4x | High |
| Q3 2024 | 8.7x | High |
ENOV's net debt is about 1.4 years of its operating earnings (EBITDA), down from 7.9 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ENOV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.6 | Neutral |
| Stochastic | 58.1 | Neutral |
ENOV's weekly RSI is 61 (neutral) and its Stochastic is 58 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
ENOV PE vs Industrials Sector
| Metric | ENOV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ENOV has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
ENOV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 31% above |
| 20 week MA | $23.0 | 20% above |
| 50 week MA | $23.7 | 17% above |
| 100 week MA | $29.2 | 5.2% below |
| 200 week MA | $41.1 | 33% below |
ENOV has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 33% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
ENOV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $62.5 | $63.3 | +1.4% |
| 2021 | $63.3 | $77.7 | +23% |
| 2022 | $77.7 | $52.9 | -32% |
| 2023 | $52.9 | $56.0 | +6% |
| 2024 | $56.0 | $44.3 | -21% |
| 2025 | $44.3 | $27.4 | -38% |
| 2026 YTD | $27.4 | $27.6 | +0.9% |
ENOV has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.